Nanjing Vishee Medical Technology Co., Ltd (688580.SS)
CNY 31.76
(-4.31%)
CNY 31.76
(-4.31%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 27.1 Million CNY | 2169.33% |
| 2022 | 1.19 Million CNY | -60.05% |
| 2021 | 2.98 Million CNY | -28.23% |
| 2020 | 4.16 Million CNY | -70.25% |
| 2019 | 14 Million CNY | -28.21% |
| 2018 | 19.5 Million CNY | -2.5% |
| 2017 | 20 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 28.25 Million CNY | 3.03% |
| 2024 Q1 | 27.42 Million CNY | 1.19% |
| 2024 Q3 | 28.06 Million CNY | -98.41% |
| 2023 Q2 | 1.23 Million CNY | 1.82% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 FY | 27.1 Million CNY | 2169.33% |
| 2023 Q4 | 27.1 Million CNY | 0.0% |
| 2023 Q1 | 1.21 Million CNY | 1.86% |
| 2022 Q2 | 2.41 Million CNY | 1.52% |
| 2022 Q1 | 2.38 Million CNY | -20.26% |
| 2022 FY | 1.19 Million CNY | -60.05% |
| 2022 Q4 | 1.19 Million CNY | 2.51% |
| 2022 Q3 | 1.16 Million CNY | -51.85% |
| 2021 Q2 | 3.54 Million CNY | 1.41% |
| 2021 Q4 | 2.98 Million CNY | 1.46% |
| 2021 FY | 2.98 Million CNY | -28.23% |
| 2021 Q1 | 3.49 Million CNY | 0.0% |
| 2021 Q3 | 2.94 Million CNY | -16.9% |
| 2020 Q3 | 4 Million CNY | -55.56% |
| 2020 FY | 4.16 Million CNY | -70.25% |
| 2020 Q1 | 9 Million CNY | -35.71% |
| 2020 Q4 | - CNY | -100.0% |
| 2020 Q2 | 9 Million CNY | 0.0% |
| 2019 Q2 | 19 Million CNY | 0.0% |
| 2019 Q4 | 14 Million CNY | 0.0% |
| 2019 FY | 14 Million CNY | -28.21% |
| 2018 FY | 19.5 Million CNY | -2.5% |
| 2017 FY | 20 Million CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |